United States — Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans — Herbals-Botanicals

← back to leaderboard

United States received 9 FDA import refusals in Herbals-Botanicals, part of Vitamins, Minerals, Proteins, and Unconventional Dietary Specialties for Humans between 2023-Q3 and 2026-Q2. Volume peaked at 3 in 2025-Q3, with the trend rising year-on-year. The most-cited issues are unapproved, unsfdietsp, and nutrit lbl. No trade baseline is published for this commodity from United States, so no per-$1B rate is shown here.

Of these, 1 were hazard refusals and 8 were paperwork refusals.

Exporting from United States? Get an email when shipments from United States are refused at the US border — before your buyers ask.

Quarterly rejections, last 12 quarters

1 2023-Q3 2023-Q3: 1 0 2023-Q4 2023-Q4: 0 0 2024-Q1 2024-Q1: 0 1 2024-Q2 2024-Q2: 1 0 2024-Q3 2024-Q3: 0 1 2024-Q4 2024-Q4: 1 0 2025-Q1 2025-Q1: 0 2 2025-Q2 2025-Q2: 2 3 2025-Q3 2025-Q3: 3 0 2025-Q4 2025-Q4: 0 0 2026-Q1 2026-Q1: 0 1 2026-Q2 2026-Q2: 1

Recent rejections